Cellcolabs vs Snipr Biome

Cellcolabs vs Snipr Biome, compared side by side on 11 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Cellcolabs is on 55/100 and Snipr Biome on 38/100.

Cellcolabs logo
CellcolabsAI-powered platform for personalized cell therapy development and manufacturing.
Try Cellcolabs
Snipr Biome logo
Snipr BiomeSNIPR Biome is a clinical-stage company developing CRISPR-based therapeutics to precisely target and eliminate specific bacteria in the human microbiome.
Try Snipr Biome

Where each one leads

Cellcolabs

  • our overall score: 55/100 against 38/100
  • domain rating: 36/100 against 31/100

Snipr Biome

  • agent readiness: 47/100 against 40/100
  • funding raised: $97.0M against $15.5M

At a glance

MeasureCellcolabsSnipr Biome
What it isAI-powered platform for personalized cell therapy development and manufacturing.SNIPR Biome is a clinical-stage company developing CRISPR-based therapeutics to precisely target and eliminate specific bacteria in the human microbiome.
CategoryBiotech, MedTech, HealthTech, Drug DiscoveryBiotech, MedTech, Genomics, Drug Discovery
Sells toBusiness modelB2BB2B
OfferingPlatformPlatform
Founded2021Not published
HeadquartersTel Aviv, IsraelCopenhagen, Denmark
StatusActiveActive

Size, funding and growth

MeasureCellcolabsSnipr Biome
Employees79Not published
Total funding$15.5M$97.0M
Latest roundNot publishedSeries B
LinkedIn followers6,563Not published

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureCellcolabsSnipr Biome
StartupHub scoreOur 0-100 rating55/10038/100
TractionNot published40/100
Search visibility2/1002/100
QualityNot published50/100
Agent readinessHow well an AI agent can read and act on the siteD (40/100)D (47/100)
Domain ratingLink authority, 0-10036/10031/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureCellcolabsSnipr Biome
CDNCloudflareNot detected
CMSNot detectedSquarespace
FrameworksNot detectedJquery
AnalyticsGoogle Tag ManagerNot detected

What users say

MeasureCellcolabsSnipr Biome
Reddit sentimentThreads we trackNot published3 positive, 0 negative across 3 threads
Snipr Biome
Danish biotech SNIPR Biome receives up to €20 million European backing to advance therapies against microbial resistance.
r/EU_Economics

Cellcolabs vs Snipr Biome: common questions

Which is better, Cellcolabs or Snipr Biome?

On our 0-100 score Cellcolabs rates higher (55/100 against 38/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 11 data points above: read the rows that match what you are buying for.

How do Cellcolabs and Snipr Biome compare on the numbers?

Cellcolabs leads on our overall score (55/100 against 38/100), domain rating (36/100 against 31/100). Snipr Biome leads on agent readiness (47/100 against 40/100), funding raised ($97.0M against $15.5M).

What do real users say about Cellcolabs and Snipr Biome?

Snipr Biome: 3 positive and 0 negative mentions across 3 Reddit threads we track, mostly in r/EU_Economics.

Read the full Cellcolabs review and pricing or the Snipr Biome review and pricing. You can also browse other Cellcolabs alternatives we track.